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EnlargedCavumSeptiPellucidi
andVergae in theFetus
ACause forConcern
Yoona K. Ho, MD, Michelle Turley, MD, Krishelle L. Marc-Aurele, MD, Marilyn C. Jones, MD,
Elise Housman, RDMS, Dawn Engelkemier, Lorene E. Romine, MD,
Paritosh C. Khanna, MD, Dolores H. Pretorius, MD
Objectives—To investigate fetal cases identified at our institution to determine
whether an enlarged cavum septi pellucidi or cavum vergae is associated with other
fetal abnormalities and whether its presence warrants more detailed investigation of
the fetus.
Methods—In a retrospective study, 15 high- and low-risk patients undergoing pre-
natal sonography who had an enlarged cavum septi pellucidi or cavum vergae identi-
fied were reviewed. Data were collected for the sonographic study indication,
gestation age at diagnosis of a prominent cavum, and associated anomalies. Follow-
up outcome data regarding further imaging, karyotype, diagnosis of brain anomaly,
and associated congenital abnormalities were obtained.
Results—Fifteen patients met the inclusion criteria. Nine patients were identified as
having a prominent cavum septi pellucidi, and 6 were identified as having a promi-
nent cavum vergae. The mean gestational age6 SD was 22.76 5.9 weeks. Eleven
patients made it to delivery. Of the 15 patients, 4 were thought to have trisomy 21,
and 13 had congenital anomalies. Outcomes included 10 major adverse outcomes, 4
cases with normal development or minor abnormalities, and 1 lost to follow-up. An
isolated dilated cavum on prenatal sonography was seen in 5 cases: 1 with lissence-
phaly on a neonatal examination, 3 premature deliveries (1 demise, 1 hospice, and 1
normal), and 1 unknown.
Conclusions—Our cohort had many associated clinical anomalies: 3 confirmed tris-
omy 21 and 1 probable trisomy 21, 2 genetic disorders, and 10 major adverse out-
comes, 5 of which were grave. Although we studied a small cohort, we conclude that
an enlarged cavum septi pellucidi or cavum vergae warrants consideration of genetic
counseling, which may include noninvasive prenatal testing (cell-free DNA), amnio-
centesis with microarray testing, or both.
Key Words—cavum; cavum septi pellucidi; fetal brain; fetus; obstetric
ultrasound
T he cavum septi pellucidi is a cavity filled with cerebrospinalfluid found in the normal developing fetal brain after 18weeks’ gestation. This cavity will normally close when the
two leaflets of the septa pellucida come together near term.1 The
cavum vergae is a second fluid-filled structure found just posterior to
the cavum septi pellucidi between the corpus callosum and the for-
nix.2 In accordance with practice guidelines (now called practice
parameters) released by the American Institute of Ultrasound in
Medicine, American College of Radiology, American College of
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ORIGINAL RESEARCH
Obstetricians and Gynecologists, and Society of Radiol-
ogists in Ultrasound, the cavum septi pellucidi should be
imaged as part of screening fetal sonographic examina-
tions.3 It has been well documented that the absence of
a cavum septi pellucidi on fetal sonography is associated
with other intracranial abnormalities, including holopro-
sencephaly, septo-optic dysplasia, corpus callosum dys-
genesis, and schizenchephaly.4–6 Normal cavum septi
pellucidi widths in relation to gestational age were
reported by Jou et al7 in 1998 and confirmed by Falco
et al1 in 2000, who added a correlation with the biparie-
tal diameter. The question arises as to what should be
done when fetal sonography shows an enlarged or bor-
derline enlarged cavum septi pellucidi or cavum vergae.
Is it a normal variant or an incidentaloma, as is often
thought by pediatric neuroradiologists? Should addi-
tional imaging (sonography or magnetic resonance im-
aging [MRI]) or follow-up be recommended? The aim
of this study was to investigate the fetal cases identified
at our institution over the last 10 years to determine
whether an enlarged cavum septi pellucidi or cavum ver-
gae is associated with other fetal abnormalities and
whether the presence of a prominent cavum septi pellu-
cidi or cavum vergae warrants more detailed investiga-
tion of the fetus.
Materials and Methods
A retrospective study of images from both high- and
low-risk patients undergoing routine prenatal sonogra-
phy at a tertiary referral center at the University of Cali-
fornia, San Diego, from 2004 to 2013 was conducted
after Institutional Review Board approval for this study
was obtained. A data log of all fetuses with anomalies
identified at the University of California Maternal Fetal
Care and Genetics Center was searched to identify
fetuses with an enlarged cavum septi pellucidi or cavum
vergae. The cavum septi pellucidi and cavum vergae
were considered enlarged and prominent if the measure-
ment exceeded the gestational age and ranges es-
tablished by Jou et al,7 Falco et al,1 and Tao et al2 by 2
SDs. Two-dimensional sonograms (15 cases) and 3-
dimensional (3D) sonograms, when available (6 cases),
were reviewed. The size of the apparently enlarged
cavum septi pellucidi or cavum vergae was remeasured,
and additional congenital anomalies were recorded.
Data from 15 patients were collected for analysis,
including the indication for the sonographic study,
gestational age at diagnosis of a prominent cavum
septi pellucidi or cavum vergae, and associated ana-
tomic anomalies. Follow-up outcome data regarding
further sonographic evaluations, fetal/neonatal MRI
examinations, aneuploidy screening, fetal/neonatal
karyotype, diagnosis of brain anomalies, associated
congenital abnormalities, neonatal physical examina-
tion/outcome, and fetal autopsy were obtained when
available.
Patients were scanned with 1 of 4 different models
of diagnostic ultrasound machines: Voluson Expert (GE
Healthcare, Wauwatosa, WI), Voluson E-8 (GE Health-
care), LOGIQ E-9 (GE Healthcare), and Sonoline
Antares (Siemens Medical Solutions, Issaquah, WA).
Images were reviewed independently by a diagnostic
radiologist or perinatologist at the time of the study. All
images were reviewed and remeasured at the time of this
retrospective review by a fetal radiologist (D.H.P.; Figure
1). Both the cavum septi pellucidi and cavum vergae
Figure 1. Normal cavum septi pellucidi showing measurement at a gestational age of 18 weeks. A, Axial image of a normal cavum septi pellucidi.
B, Measurement cursors show that the cavum septi pellucidi measures 2.1mm.
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were visualized, and the width was measured from an
axial view of the brain (Figure 2). Three-dimensional
sonograms were viewed from the multiplanar display
(Figure 3).
Results
Fifteen patients who met the inclusion criteria were
identified among approximately 25,620 patients
examined by sonography during the study period.
Indications for fetal sonography included abnormal
serum screening results (5), evaluation for abnormal-
ities seen on outside imaging (6), evaluation given a
family history of a congenital anomaly (1), and rou-
tine follow-up (3). Nine patients were identified as
having an enlarged cavum septi pellucidi by the read-
ing radiologist or perinatologist at the time of
the evaluation, and 6 were identified as having a
Figure 2. Normal cavum vergae showing measurement at a gestational age of 18 weeks. A, Three-dimensional image of a normal cavum vergae.
B, Measurement cursors show that the cavum vergae measures 1.6mm. Multiplanar images are as follows: A, axial plane; B, coronal plane; and
C, sagittal plane.
Figure 3. Normal and enlarged cavum septi pellucidi on 3D multiplanar images. A, Normal cavum septi pellucidi (long arrows) in a fetus at a
gestational age of 20 weeks 6 days. B, Enlarged cavum septi pellucidi (long arrows) in fetus at a gestational age of 20 weeks 2 days. Three-
dimensional axial (A) and coronal (B) planes show substantial differences between the normal and enlarged cavum septi pellucidi, whereas sagit-
tal (C) images are similar in appearance. Of note, the septum seen within the cavum septi pellucidi of the fetus in B is not associated with fornices.
Three-dimensional sonography shows 3 orthogonal planes depicting the septum (short arrow) within the cavum septi pellucidi and cavum vergae
above the level of the fornices.
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prominent cavum vergae. Overall, there were 3 cases
of an isolated enlarged cavum septi pellucidi and 2
cases of an isolated enlarged cavum vergae.
At the time of the sonographic evaluation, the
maternal age ranged from 14 to 42 years and the mean
maternal age6 SD was 306 7.7 years. The mean gesta-
tional age was 22.76 5.9 weeks at the time of the first
sonographic evaluation in which a prominent cavum
septi pellucidi or cavum vergae was noted (Table 1).
The mean age at delivery was 36.46 3.7 weeks and
ranged from 30 to 40 weeks. Five of the 11 patients who
made it to delivery were preterm, whereas 6 were term
deliveries. The severity of outcomes is given in Table 2.
One patient was lost to follow-up before delivery; 2
patients had intrauterine fetal demise; 2 had neonatal
demise; and 1 went to hospice after intraventricular
hemorrhage related to prematurity. The patient lost to
follow-up had been referred from out of the country and
was presumed to have returned home.
Of the 15 patients, 5 were thought to have chromo-
somal anomalies based on either cell-free DNA testing
or amniocentesis. Of these 5, 3 were confirmed to have
trisomy 21 (cases 2, 12, and 14). One patient had a com-
plex deletion on the Y chromosome known to affect fer-
tility but thought to be unrelated to a prominent cavum
septi pellucidi (case 1). Another patient had a positive
cell-free DNA test result for trisomy 13 but was found to
have no abnormality at birth (case 4; Figure 4). One
fetus with an unconfirmed karyotype had a positive
trisomy 21 screen result (>1 in 10 risk) with cystic
hygroma, pericardial effusion, an absent stomach, and
ascites and was suspected to have trisomy 21 (case 11).
Of the remaining 10 patients, 4 had confirmed normal
amniocentesis, and the remaining 6 had unconfirmed
karyotypes (Table 1).
Congenital anomalies were found in 13 patients
(Table 3) in the cohort, and 1 appeared to be normal
structurally. Anomalies were seen in 14 fetuses prenatally
(1 had no abnormalities at delivery), and additional major
anomalies were identified after delivery in 2 cases (cases 1
and 13). Anomalies confirmed in the neonates were var-
ied and included brain anomalies (3), congenital heart dis-
ease (4), and myotonic dystrophy (1; Table 2). It should
be noted that a history of maternal myotonic dystrophy
was present in the case with myotonic dystrophy.
Adverse outcomes occurred in 10 cases (Table 2).
Two cases had intrauterine fetal demise: 1 had a trisomy
21 karyotype with echogenic kidneys (Figure 5), and the
other had a positive trisomy 21 screen result (>1 in 10
risk) with cystic hygroma, pericardial effusion, an absent
stomach, and ascites (Table 1). Two cases had neonatal
demise: 1 with tetralogy of Fallot and vermian hypopla-
sia (Figure 6) and 1 with preterm delivery at 31 weeks
with chorioamnionitis. One patient was transferred to a
hospice with an abnormal karyotype, inoperable pulmo-
nary vein stenosis, and hydrocephalus from grade 3
hemorrhage. In addition, 1 patient had lissencephaly
with an intellectual disability and a seizure disorder, and
1 had type 1 myotonic dystrophy with substantial physi-
cal and intellectual impairment by 5 years. Lastly, 2 had
major congenital heart disease, and 1 had trisomy 21.
Isolated enlargement of the cavum on prenatal
sonography was seen in 5 cases (Table 4). The out-
comes were as follows: 1 was premature but normal
(case 15); 1 had fetal MRI showing decreased sulcation
and neonatal MRI showing lissencephaly (case 13); 1
had demise related to prematurity (case 6); 1 had hos-
pice admission related to prematurity and congenital
heart disease (case 1); and 1 was lost to follow-up
(case 9).
During the review of prominent cavum septi pellu-
cidi cases, it was found that of the 9 cases that were
called “enlarged cavum septi pellucidi” on clinical
reports, although all measurements of the cavum septi
pellucidi were above the mean, 7 were greater than 2
SDs; 1 was near the cutoff (case 3); and 1 was within 2
SDs (case 6) according to the data published (Table
1).1,2,7 The cavum vergae was called enlarged in 8 cases,
and 5 had no reference tables available because of gesta-
tional age; 2 were greater than 2 SDs; and 1 was near
the cutoff (only 25 cases in the published table by Tao
et al)2. Note that 1 fetus (case 9) had both a prominent
cavum septi pellucidi and cavum vergae. The outcomes
of these patients are given in Table 1.
Discussion
Established Normal Values for the Cavum Septi
Pellucidi and Cavum Vergae
Falco et al1 reported that the cavum septi pellucidi can
be seen in 40% of fetuses as early as 15 weeks, in 82%
from 16 to 17 weeks, in 100% from 18 to 37 weeks, and
in 79% from 38 to 41 weeks. In our clinical practice, it is
common to be unable to visualize the cavum septi pellu-
cidi before 20 weeks, and patients are asked to return at
22 weeks for a follow-up sonogram. The mean width of
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the cavum septi pellucidi has been associated with gesta-
tional age, and ranges have been established by Jou
et al,7 Falco et al,1 and Tao et al.2 The mean width and
anteroposterior diameter of the cavum septi pellucidi
have been shown to differ significantly between the sec-
ond and third trimesters and to correlate with the gesta-
tional age and biparietal diameter. In a study by
Serhatlioglu et al,8 the mean second-trimester width was
3.1mm, and the mean anteroposterior diameter was
7.7mm; the mean third trimester width was 5mm, and
the mean anteroposterior diameter was 11.7mm. In
addition, Chaoui et al9 reported a linear increase in the
cavum septi pellucidi width relative to the biparietal
diameter, with mean cavum septi pellucidi widths of 3.0
to 6.3mm for biparietal diameters of 40 to 90mm,
respectively.
Cavum vergae visualization was examined in a study
by Tao et al2; it was only visualized at a rate of 7.8% (25
of 322) with a width of 6.7mm (range, 5.1–9.0mm) in
their study of 322 uncomplicated singleton pregnancies
in the second and third trimesters using routine sono-
graphic examinations. Using 3D sonography, another
study was able to visualize the cavum vergae in 202 con-
secutive fetuses, but no measurements were reported.10
More recently, Unal et al11 evaluated the cavum vergae
in 336 healthy third-trimester fetuses with routine trans-
abdominal sonography and found that cavum vergae clo-
sure increased with gestational age, with 100%
visualization of the cavum vergae at 28 weeks or earlier
and 42% visualization at 37 to 41 weeks. The study also
evaluated correlation between the biparietal diameter,
cavum vergae volume, and cavum vergae thickness and
found no significant correlation between the biparietal
diameter and cavum vergae thickness or volume in
fetuses at the same gestational age.
The presence of the cavum septi pellucidi decreases
with postnatal age; however, the reported prevalence in
the literature is widely variable, likely because of differen-
ces in imaging modalities and study populations. There
is a dramatic decrease in the presence of the cavum septi
pellucidi detected on autopsy during the first few
months of life, from 97% during the first week of life to
15% at 3 to 6 months of life.12 The cavum septi pellucidi
size in the term neonate is similar to that in the second-
to third-trimester fetus, with a mean width of 5.1mm;
widths of greater than 9.5mm and depths of greater
than 8.1mm are considered outside the normal range.13
In adults, the cavum septi pellucidi is typically measuredTa
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anterior to posterior based on the number of MRI slices
on which it is visible, with a length of greater than 6mm
considered abnormal.14 Criteria for a normal versus
abnormal cavum septi pellucidi in the young pediatric
population are not well established, although a similar
anteroposterior measurement threshold of 6mm
has been used for studying the association between
childhood-onset schizophrenia and 22q11 deletion
syndrome.15,16
Prominent Cavum Septi Pellucidi in the Fetus
Chromosomal anomalies are associated with a promi-
nent cavum septi pellucidi. Recently, significantly larger
cavum septi pellucidi widths were found in 139 fetuses
with autosomal trisomies compared to 267 euploid
fetuses.17 Ninety-two percent of fetuses with trisomy 18,
42% of fetuses with trisomy 21, and 37.5% of fetuses
with trisomy 13 had a cavum septi pellucidi width above
the 95th percentile compared to euploid fetuses. How-
ever, the actual difference in width measurements was
small, with a substantial overlap of ranges for aneuploid
and euploid fetuses. Similarly, our cohort had 3 fetuses
with trisomy 21, another with a high suspicion of tris-
omy 21 with a positive screen result and anomalies com-
monly seen with trisomy 21 (case 11), and 1 with a
positive screen results and risk of greater than 1 in 10
who was lost to follow-up; all 5 cases had a cavum septi
pellucidi exceeding the normal range. In addition, 4 of
these 5 patients had an enlarged cavum vergae detected
on sonography. An enlarged cavum septi pellucidi has
also been reported prenatally in fetuses with 22q11 dele-
tion syndrome. In a study of 37 fetuses with 22q11
Table 2. Outcomes Based on Severity
Normal Development1 /2
Minor Anomalies Major Anomalies Grave Outcomes Unknown
Case 3 P Dandy-Walker
variant
Case 5 T Myotonic
dystrophy
Case 1 P Intraventricular hemorrhage,
congenital heart disease,
hospice
Case 9 Lost to
follow-up
Case 4 T Normal Case 8 T Congenital heart
disease,
trisomy 21
Case 2 P Congenital heart disease, possible
Dandy-Walker variant, trisomy
21, neonatal demise
Case 7 T Polydactyly Case 10 T Congenital heart
disease
Case 6 P Chorioamnionitis,
neonatal demise
Case 15 P Hypospadias Case 13 T Lissencephaly Case 11 Suspected trisomy 21,
fetal demise
Case 14 Trisomy 21 Case 12 Trisomy 21, fetal demise
Total 4 5 5 1
P indicates preterm; T, term.
Figure 4. Changes in cavum septi pellucidi size with fetal growth. A, Axial image of a 21-week fetus shows a normal cavum septi pellucidi meas-
uring at the mean for gestational age. B, This same fetus at 29 weeks now has an enlarged cavum septi pellucidi measuring between 1 and 2 SDs
above the mean for gestational age.This fetus had ambiguous genitalia and 47,XX113 on cell-free DNA testing.The neonate appeared normal at
delivery.
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deletion syndrome, 67.5% had a dilated cavum septi pel-
lucidi in the second half of gestation.9 Although further
investigations examining the importance of incidental
cavum septi pellucidi enlargements and associations with
other anomalies are needed, genetic counseling and a
discussion of noninvasive and diagnostic prenatal testing
should be considered during pregnancy
Fetal anomalies and poor neonatal outcomes have
been associated with a prominent cavum septi pellucidi
and cavum vergae. Several studies and case reports have
suggested the association of a prominent cavum septi
pellucidi and cavum vergae on prenatal sonography with
fetal anomalies and poor outcomes. Our study cohort
had major adverse outcomes in 10 cases and clinical
Table 3. Reported Prenatal and Postnatal Anomalies in Patients
Anomalies in Viable Patients Anomalies in IUFD Patients
Cortical blindness
Dandy-Walker variant
Hearing loss
Intraventricular hemorrhage
Lissencephaly
Macrocephaly
Myotonic dystrophy
Polydactyly
Pulmonary hypertension
Pulmonary vein stenosis
Situs inversus totalis
Tetralogy of Fallot
Transposition of great arteries
Absent stomach
Anhydramnios
Ascites
Cystic hygroma
Echogenic focus in left ventricle
Echogenic kidneys
Lagging long bone growth
Nuchal cyst
Pericardial effusion
Pleural effusion
Trisomy 21
IUFD indicates intrauterine fetal demise.
Figure 5. Abnormal cavum vergae at a gestational age of 18 weeks in a fetus with 47,XY121 and intrauterine demise at 35 weeks. A, Three-
dimensional image of an abnormal cavum vergae. B, Measurement cursors show that the cavum vergae measures 3.8mm. Multiplanar images
are as follows: A, axial plane; B, coronal plane; and C, sagittal plane.
Figure 6. Enlarged cavum septi pellucidi in a fetus at a gestational age of 25 weeks 3 days who had multiple anomalies, 47,XY121, and neonatal
demise. A, Axial image showing an enlarged cavum septi pellucidi. B, Measurement cursors show that cavum septi pellucidi measures 9.3mm.
Other fetal sonographic findings included a double bubble, an absent nasal bone, a ventricular septal defect, an overriding aorta, an intracardiac
echogenic focus, and a possible Dandy-Walker variant.C andD, Coronal sonogram (C) and coronal T2-weighted MRI (D) of the neonate at 1 day
old (adjusted gestational age, 30 weeks 5 days) showing an enlarged cavum septi pellucidi measuring 9mm. Neonatal findings included tetralogy
of Fallot, a Dandy-Walker variant with vermian hypoplasia, cortical blindness, deafness, and 47,XY121.This patient had neonatal demise.
Ho et al—Enlarged Cavum Septi Pellucidi and Vergae in the Fetus
J Ultrasound Med 2017; 36:1657–1668 1665
anomalies in 13, which were further discussed in the
“Results” section. Outcomes included fetal demise, neo-
natal demise, and major anomalies such as lissencephaly,
myotonic dystrophy, and congenital heart disease. In a
large study of 11,200 pregnant women reported by
Bronshtein and Weiner18 in 1992, only 8 cases of a
cavum vergae measuring 5mm or greater were identi-
fied; the size of the cavum septi pellucidi was not dis-
cussed in that cohort. Only 1 of these 8 cases showed a
normal karyotype, lack of associated anomalies, and nor-
mal development at 6 months. One had a chromosomal
translocation, and the others had normal karyotypes
with a range of abnormalities, including fetal growth
restriction with subsequent normal development at 12
months, an Ebstein anomaly, arthrogryposis, polycystic
kidneys, cystic hygroma, short stature, hydrocephalus,
and periventricular calcifications. In another report of 3
cases looking at midline cystic structures larger than
10mm diagnosed prenatally as an enlarged cavum ver-
gae, 1 had associated ventriculomegaly and lumbar
meningocele; 1 required shunting postnatally for intra-
cranial hypertension; and 1 was asymptomatic.19 A sin-
gle report was made of a fetus with a large cavum septi
pellucidi and cavum vergae (12.6mm) who was found
to have midgut malrotation postnatally.20
An enlarged cavum septi pellucidi or cavum vergae
without other anomalies is of unclear importance. In our
study, 2 major adverse outcomes were identified: 1 case
had relatively normal sonographic findings (lateral ven-
tricles at the upper limits of normal) that was later found
to have lissencephaly, and 1 case had congenital heart
disease that went to a hospice for complications of pre-
maturity. Another case had neonatal demise from pre-
mature abruption. Only 1 case had a normal outcome.
Occasionally, differentiation of a prominent cavum
septi pellucidi from other cystic cerebral lesions on fetal
sonography may be challenging. We have found that 3D
sonography is particularly helpful in differentiating a nor-
mal cavum septi pellucidi and cavum vergae from patho-
logic lesions. The cursor dot or reference dot can be
positioned in the lesion and seen on all 3 orthogonal
planes to identify the structure (Figure 1). Differential
considerations of a midline cystic lesion include an
arachnoid cyst, an enlarged third ventricle, a vein of
Galen malformation, an interhemispheric cyst with agen-
esis of the corpus callosum, agenesis of the corpus cal-
losum with the subarachnoid space extending into the
region of the cavum septi pellucidi, a porencephalic cyst,
a glioependymal cyst, schizencephaly, intracranial hem-
orrhage, and a cystic neoplasm. Careful evaluation of the
location of the lesion and adjacent abnormalities and the
use of color Doppler facilitate correct diagnosis. Occa-
sionally, serial follow-up examinations to evaluate inter-
val changes or MRI may be necessary for definitive
diagnosis. In a series of 19 cases of interhemispheric
cystic lesions on prenatal sonography, 12 were related to
an enlarged physiologic structure (cavum septi pellucidi,
cavum vergae, and velum interpositum cysts) with a
median size of 10mm.21 These lesions were stable or
resolved. Only borderline ventriculomegaly was present
in 2 cases, and pediatric follow-up showed normal neu-
rodevelopment. Conversely, pathologic cystic lesions
were larger (median size of 40mm), and most showed
associated anomalies of callosal agenesis or hypogenesis
with hydrocephalus.21
Prominent Cavum Septi Pellucidi Postnatally
Although a persistent cavum septi pellucidi beyond
infancy may be a normal variant, an enlarged cavum
septi pellucidi may indicate abnormal neurodevelop-
ment. The septum pellucidum is part of the limbic sys-
tem, which affects memory, behavior, and emotion.
Aberrations in the limbic system have been associated
with neuropsychiatric diseases.22 Multiple studies have
shown increased cavum septi pellucidi prevalence and
size in neuropsychiatric disorders, particularly schizo-
phrenia.14,23–25 In a large meta-analysis, the incidence of
a large cavum septi pellucidi was significantly higher in
schizophrenia spectrum disorders compared to controls
(odds ratio, 1.59).14 Schizophrenia has also been highly
associated with 22q11 deletion syndrome; in a study of
78 adults with 22q11 deletion syndrome, 22.6% were
Table 4. Isolated Cases of Enlarged Cavum Septi Pellucidi and
Cavum Vergae
Case
Term vs
Preterm
Delivery Clinical Outcome
1 Preterm Hospice for intraventricular
hemorrhage related to prematurity
and congenital heart disease
6 Preterm Neonatal demise from
premature abruption
9 Unknown Lost to follow-up
13 Term Lissencephaly
15 Preterm Normal development
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found to have schizophrenia.26 Children with chromo-
some 22q11.2 deletion syndrome have been found to
have a greater cavum septi pellucidi anteroposterior
length (mean of 12.58mm compared to mean of
2.31mm in controls) and volume (916.13mm3 com-
pared to 12.83mm3 in controls).16 An enlarged cavum
septi pellucidi has also been associated with disruptive
behavior disorder in youth, bipolar disorder, posttrau-
matic stress disorder, adolescent-onset opiate depend-
ence, and lower IQ scores.27–31 During our study period,
we had 2 cases of an enlarged cavum septi pellucidi diag-
nosed in neonates, 1 of which was the index case that
prompted this study. Both neonates were born preterm,
and 1 developed chronic lung disease as a complication
of prematurity. The other case had a normal clinical out-
come with appropriate development.
The presence of the cavum septi pellucidi in adults
has been linked to traumatic brain injury, and the cavum
septi pellucidi size has been shown to correlate with the
injury severity in pediatric brain trauma.32 Injury to the
right entorhinal cortex and bilateral hippocampi is
strongly correlated with the cavum septi pellucidi size.32
Similarly, in adults with schizophrenia, decreased vol-
umes in the left temporal lobe (specifically the left amyg-
dala and anterior hippocampus), left parahippocampal
gyrus, and bilateral amygdala have been associated with
a large cavum septi pellucidi.33–36 Although the mecha-
nisms may be different, an enlarged cavum septi pellucidi
postnatally may reflect developmental or acquired
abnormalities of bordering structures in the limbic
system.32,37
Limitations
Limitations of this study included the following: (1) lim-
ited long-term follow-up on a prenatally diagnosed large
cavum septi pellucidi has been done to date—in our
study or in the literature; (2) substantial overlaps in the
ranges of normal and abnormal measurements of the
cavum septi pellucidi and cavum vergae have been
reported; (3) a limited number of patients were included
in the study; and (4) 1 patient was lost to follow-up.
Conclusions
This study examined an enlarged cavum septi pellucidi
and cavum vergae in routine prenatal sonographic
examinations and their association with prenatal and
neonatal anomalies. In our study, 13 of 15 cases had
associated clinical anomalies; 4 had abnormal karyo-
types; 2 had genetic disorders; and 10 had major adverse
outcomes. Overall, our cohort had 3 confirmed cases of
trisomy 21 and 1 additional suspected case, which corre-
sponds to the supporting literature. The importance of
an isolated enlarged cavum vergae or cavum septi pellu-
cidi is unclear. We had 5 cases of an isolated enlarged
cavum septi pellucidi or cavum vergae: 1 had congenital
heart disease; 1 had lissencephaly; and 1 had normal
development. Although further studies are needed to
investigate this association of an enlarged cavum septi
pellucidi or cavum vergae with anomalies, we conclude
that these findings on routine sonograms warrant con-
sideration of genetic counseling, which may include non-
invasive prenatal testing (cell-free DNA), amniocentesis
with microarray testing, or both. Future studies with
larger cohorts are needed to examine whether fetal brain
MRI should be recommended in isolated cases of an
enlarged cavum.
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